We have read and reviewed the article entitled as ''Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection'' by Saito et al. with interest [1]. The authors state that the choroidal thickness (CT) significantly decreased after switching to intravitreal aflibercept injection in eyes with polypoidal choroidal vasculopathy (PCV) refractory to ranibizumab. Intravitreal aflibercept (2 mg/0.05 ml) injections were administered for three consecutive months, including a loading dose followed by further injections in the following 2 months. The authors found significant reductions in subfoveal CT (from 203 to 171 lm), and in central retinal thickness (from 249 to 161 lm) at month 6. We would like to ask for further details, and contribute to the article.
To the Editor,
We have read and reviewed the article entitled as ''Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection'' by Saito et al. with interest [1] . The authors state that the choroidal thickness (CT) significantly decreased after switching to intravitreal aflibercept injection in eyes with polypoidal choroidal vasculopathy (PCV) refractory to ranibizumab. Intravitreal aflibercept (2 mg/0.05 ml) injections were administered for three consecutive months, including a loading dose followed by further injections in the following 2 months. The authors found significant reductions in subfoveal CT (from 203 to 171 lm), and in central retinal thickness (from 249 to 161 lm) at month 6. We would like to ask for further details, and contribute to the article.
We wonder whether the authors considered some additional important parameters when obtaining optical coherence tomography (OCT) measurements. Of note, CT has a significant diurnal variation [2, 3, 4] . The choroid could increase its thickness by 50 % in an hour, and quadruple its thickness in a few days [2] . Kee et al. demonstrate that the choroid could thin very rapidly, by about 100 lm in 3-4 h in young chicks [3] . Tan et al. measured CT in humans at 2-h intervals between 9:00 AM and 5:00 PM, and determined significant differences in CT among all measurement points [4] . Tan et al. found mean diurnal amplitude of CT as 33.7 ± 21.5 lm (range 3-67 lm).
Usui et al. evaluated subfoveal choroidal thickness (SFCT) in healthy subjects, and measured SFCT every 3 h over a 24-h period. In that study, they show that diurnal variations of CT might be as high as 65 lm (range 8-65 lm) [5] .
Therefore, a significant effect of physiological fluctuation on test measurement results and statistical analyses should be expected when assessing CT measurements. We suggest performing OCT measurements along with preoperative and postoperative follow-up examinations at set times, and at certain time periods of the day.
Additionally, various local or systemic physiological/pathological conditions affect CT [2] . We are curious whether the authors analyzed the participants of this study for systemic diseases, medication history and body mass index, as well as for sleeping and exercise status, consuming alcohol and beverages with or without caffeine before OCT tests. We also wonder what were the systemic blood pressure measurement results.
Finally, the participants of this study are elderly (mean age 75.7 ± 5.8 years, range 60-88 years). Since various systemic or local diseases, and medications may have significant effects on CT, we wonder what were the systemic disease statuses and medication history of the patients [2] . All those factors may significantly have affected the results of the study and statistical analysis. We suggest that the authors should consider and mention all those parameters in the study. 
